MSD Partners’s Pfizer PFE Stock Holding History

MSD Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-2,723,729	Closed	-$74.2M	–	65
2013 Q3	$74.2M	Sell	2,723,729 -2,635,000	-49%	-$71.7M	2.79%	10
2013 Q2	$142M	Buy	+5,358,729	New	+$148M	7.8%	3

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MSD Partners's PFE Position: Q4 2013 in Review

MSD Partners sold out of Pfizer (PFE) in Q4 2013, closing a stake of 2,723,729 shares — an estimated $74.2M sold.

MSD Partners first reported a position in PFE in Q2 2013 and held it in 2 quarters. The position peaked at $142M in Q2 2013. 1,735 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

MSD Partners reported no remaining Pfizer position as of Q4 2013 after selling out during the quarter.
MSD Partners sold 2,723,729 Pfizer shares in Q4 2013, an estimated $74.2M.
MSD Partners first reported a position in Pfizer in Q2 2013 and held it in 2 quarters.
MSD Partners's Pfizer position peaked at $142M in Q2 2013.
1,735 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on MSD Partners's 13F filing for Q4 2013, filed 14 Feb 2014.